Abramson Cancer Center
🇺🇸United States
Neoadjuvant Pembrolizumab and Lenvatinib for Renal Cell Carcinoma
Early Phase 1
Recruiting
- Conditions
- Renal Cell Carcinoma
- Interventions
- First Posted Date
- 2023-02-17
- Last Posted Date
- 2025-03-03
- Lead Sponsor
- Abramson Cancer Center at Penn Medicine
- Target Recruit Count
- 30
- Registration Number
- NCT05733715
- Locations
- 🇺🇸
Abramson Cancer Center at University of Pennsylvania, Philadelphia, Pennsylvania, United States
QOL and Sarcopenia in Patients With Ascites
Recruiting
- Conditions
- Ascites HepaticAscites, Malignant
- First Posted Date
- 2023-02-14
- Last Posted Date
- 2024-07-31
- Lead Sponsor
- Abramson Cancer Center at Penn Medicine
- Target Recruit Count
- 70
- Registration Number
- NCT05726747
- Locations
- 🇺🇸
University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States
Sequential EHR Based Interventions to Increase Genetic Testing for Breast and Ovarian Cancer Predisposition
Not Applicable
- Conditions
- Gene Mutation-Related CancerGenetic Predisposition to DiseaseBreast Cancer FemaleOvarian CancerHereditary Breast and Ovarian CancerHereditary DiseasesHereditary Cancer Syndrome
- Interventions
- Other: Sequential EHR Communications
- First Posted Date
- 2023-02-10
- Last Posted Date
- 2025-01-29
- Lead Sponsor
- Abramson Cancer Center at Penn Medicine
- Target Recruit Count
- 450
- Registration Number
- NCT05721326
- Locations
- 🇺🇸
Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, United States
Shortened Course Adjuvant Radiotherapy Following TORS
Phase 2
Recruiting
- Conditions
- HPV-Associated Oropharyngeal Squamous Cell Carcinoma
- Interventions
- Radiation: Shortened Course Adjuvant Radiotherapy Following TORS
- First Posted Date
- 2023-02-06
- Last Posted Date
- 2024-07-05
- Lead Sponsor
- Abramson Cancer Center at Penn Medicine
- Target Recruit Count
- 104
- Registration Number
- NCT05714657
- Locations
- 🇺🇸
Lancaster General Hospital, Lancaster, Pennsylvania, United States
🇺🇸University of Pennsylvania, Philadelphia, Pennsylvania, United States
🇺🇸Pennsylvania Hospital, Philadelphia, Pennsylvania, United States
Behavioral Economic Approaches for Population-Based Colorectal Cancer Screening
Not Applicable
Active, not recruiting
- Conditions
- Colorectal Cancer
- Interventions
- Behavioral: Visit-Based Nudge/TextBehavioral: No Direct Patient OutreachBehavioral: No Nudge/Text
- First Posted Date
- 2023-01-23
- Last Posted Date
- 2024-08-09
- Lead Sponsor
- Abramson Cancer Center at Penn Medicine
- Target Recruit Count
- 20000
- Registration Number
- NCT05693649
- Locations
- 🇺🇸
Penn Medicine, Philadelphia, Pennsylvania, United States
FES BPET-DBT in Newly Diagnosed Breast Cancer
- First Posted Date
- 2022-12-21
- Last Posted Date
- 2025-02-11
- Lead Sponsor
- Abramson Cancer Center at Penn Medicine
- Target Recruit Count
- 20
- Registration Number
- NCT05659797
- Locations
- 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States
Improve Outcomes for Older Allogeneic Transplant Recipients
Not Applicable
Recruiting
- Conditions
- Allogeneic Transplantation
- Interventions
- Behavioral: Exercise Program (Cohort A Prehab)Behavioral: Exercise Program (Cohort B Rehab)
- First Posted Date
- 2022-11-10
- Last Posted Date
- 2025-04-17
- Lead Sponsor
- Abramson Cancer Center at Penn Medicine
- Target Recruit Count
- 72
- Registration Number
- NCT05612789
- Locations
- 🇺🇸
Penn Medicine, Philadelphia, Pennsylvania, United States
Predictive Analytics and Behavioral Nudges to Improve Palliative Care in Advanced Cancer
Not Applicable
Completed
- Conditions
- Cancer
- Interventions
- Other: EHR Nudge
- First Posted Date
- 2022-10-21
- Last Posted Date
- 2025-02-06
- Lead Sponsor
- Abramson Cancer Center at Penn Medicine
- Target Recruit Count
- 562
- Registration Number
- NCT05590962
- Locations
- 🇺🇸
Tennessee Oncology, PLLC, Nashville, Tennessee, United States
Project RESIST: Evaluating the Effects of Anti-smoking Inoculation Messages Among Young Adult Sexual Minority Women
Not Applicable
Completed
- Conditions
- Cigarette Smoking Behavior
- Interventions
- Other: Culturally Tailored Anti-Smoking Messages
- First Posted Date
- 2022-08-12
- Last Posted Date
- 2024-07-31
- Lead Sponsor
- Abramson Cancer Center at Penn Medicine
- Target Recruit Count
- 2591
- Registration Number
- NCT05499520
- Locations
- 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States
Neoadjuvant PD-1 Blockade in Resectable Merkel Cell Carcinoma
- First Posted Date
- 2022-08-10
- Last Posted Date
- 2025-01-30
- Lead Sponsor
- Abramson Cancer Center at Penn Medicine
- Target Recruit Count
- 15
- Registration Number
- NCT05496036
- Locations
- 🇺🇸
Penn Medicine, Philadelphia, Pennsylvania, United States
© Copyright 2025. All Rights Reserved by MedPath